Antibody to α4β7 integrin for ulcerative colitis [1] (multiple letters)

New England Journal of Medicine

Volumn 353, Issue 11, 2005, Pages 1180-1181

  Danese, Silvio ^a   De La Rue, Sarah A ^b   Gasbarrini, Antonio ^a   Feagan, Brian G ^c   Fox, Irving H ^d   Kishimoto, Kei ^d  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

^d MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MLN 02; NATALIZUMAB; INTEGRIN; INTEGRIN ALPHA4BETA7; MLN02 ANTIBODY, HUMAN; MONOCLONAL ANTIBODY; VERY LATE ACTIVATION ANTIGEN 4;

CLINICAL TRIAL; DRUG SAFETY; HUMAN; LETTER; LIGAND BINDING; MICROVASCULATURE; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RISK ASSESSMENT; T LYMPHOCYTE; ULCERATIVE COLITIS; DRUG EFFECT; IMMUNOLOGY; JC VIRUS; LEUKOENCEPHALOPATHY; NOTE; PHYSIOLOGY; VIRUS ACTIVATION;

ANTIBODIES, MONOCLONAL; COLITIS, ULCERATIVE; HUMANS; INTEGRIN ALPHA4BETA1; INTEGRINS; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; VIRUS ACTIVATION;

EID: 24944582970     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMc051937     Document Type: Letter

References (0)